Skip to main content Accessibility help
×
Home

Lethal Catatonia and Neuroleptic Malignant Syndrome: A Dopamine Receptor Shut-down Hypothesis

  • Abdelkarim A. Osman (a1) and Mohamed H. Khurasani (a1)

Abstract

Background

Lethal catatonia and neuroleptic malignant syndrome (NMS) have been suggested to have a common neurochemical cause. We hypothesise that both conditions may be due to a sudden and massive blockade of dopamine neurotransmitters.

Method

NMS was diagnosed in psychotic in-patients treated with neuroleptics if four features were present: diffuse severe rigidity, altered level of consciousness, hyperpyrexia and autonomic instability.

Results

Over three years, five NMS cases were diagnosed. Two presented with catatonic features and were diagnosed as acute reactive psychosis. Their neuroleptic doses were small, arguing for a particular sensitivity in these two cases.

Conclusion

The sensitivity of two patients with catatonic features who developed NMS with small doses of neuroleptics supports a common neurochemical basis for the two conditions.

Copyright

Corresponding author

Dr Osman, PO Box 50505 (176), King Fahd Hospital, Jeddah, Saudi Arabia

References

Hide All
Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 15871590.
Adityanjee, , Singh, S., Singh, G., et al (1988) Spectrum concept of neuroleptic malignant syndrome. British Journal of Psychiatry, 153, 107111.
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 7983.
Fujitake, J., Kuno, S. & Nishitani, H. (1984) Neuroleptic malignant syndrome-like state in eight patients with Parkinsonism. Rinsho Shinkeigaku, 24, 371378.
Kellam, A. M. P. (1987) The neuroleptic malignant syndrome, so-called: a survey of the world literature. British Journal of Psychiatry, 150, 752759.
Kellam, A. M. P. (1990) The (frequently) neuroleptic malignant syndrome. Current Opinion in Psychiatry, 4, 3437.
Levenson, J. L. (1985) Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 11371145.
Mann, S. C., Caroff, S. N., Bleier, H. R., et al (1986) Lethal catatonia. American Journal of Psychiatry, 143, 13741381.
Osman, A., Al Khateeb, S. & Ali, A. (1993) The pattern of admission to Jeddah Psychiatric Hospital. Saudi Medical Journal, 14, 334339.
Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717725.
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome agent and host interaction. Acta Psychiatrica Scandinavica, 73, 337347.
White, D. & Robins, A. H. (1991) Catatonia: harbinger of the neuroleptic malignant syndrome. British Journal of Psychiatry, 158, 419421.

Lethal Catatonia and Neuroleptic Malignant Syndrome: A Dopamine Receptor Shut-down Hypothesis

  • Abdelkarim A. Osman (a1) and Mohamed H. Khurasani (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Lethal Catatonia and Neuroleptic Malignant Syndrome: A Dopamine Receptor Shut-down Hypothesis

  • Abdelkarim A. Osman (a1) and Mohamed H. Khurasani (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *